Hypercalcaemia as an immune-related adverse event secondary to ipilimumab and nivolumab therapy in a patient with metastatic renal cell carcinoma
Year: 2026
Type: article
Study design: Case Report
Source: BMJ Case Reports
Authors: Hala Osman, Aditya Sanjeevi, Chao-yu Hsu
Institution: Rochester General Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128525414